Aptamer-Based Antibacterial and Antiviral Therapy against Infectious Diseases | Journal of Medicinal Chemistry
![MolMed: AIFA approva commercializzazione Zalmoxis. Titolo vola in Borsa - Economia e Finanza - Repubblica.it MolMed: AIFA approva commercializzazione Zalmoxis. Titolo vola in Borsa - Economia e Finanza - Repubblica.it](https://images.teleborsa.it/t/aumento/36107.t.W600.H340.M4.jpg)
MolMed: AIFA approva commercializzazione Zalmoxis. Titolo vola in Borsa - Economia e Finanza - Repubblica.it
![European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.2119%2Fmolmed.2009.00094/MediaObjects/10020_2009_1511371_Fig2.jpg)
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text
![Antioxidants | Free Full-Text | Cellular Aging Characteristics and Their Association with Age-Related Disorders Antioxidants | Free Full-Text | Cellular Aging Characteristics and Their Association with Age-Related Disorders](https://www.mdpi.com/antioxidants/antioxidants-09-00094/article_deploy/html/images/antioxidants-09-00094-g001.png)
Antioxidants | Free Full-Text | Cellular Aging Characteristics and Their Association with Age-Related Disorders
Press release issued by MolMed S.p.A. at the request of AGC Inc. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PA
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHER
Press release issued by MolMed S.p.A. upon request of AGC Inc. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART
MolMed receives IND clearance by the FDA to conduct a Phase III trial of TK for high-risk leukaemia in the United States
![Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer - ScienceDirect Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1535610822002173-fx1.jpg)